Latest news with #Cyprys
Business Insider
29-07-2025
- Business
- Business Insider
T Rowe Price (TROW) Gets a Hold from Morgan Stanley
In a report released today, Michael Cyprys from Morgan Stanley maintained a Hold rating on T Rowe Price, with a price target of $112.00. The company's shares closed today at $106.00. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cyprys covers the Financial sector, focusing on stocks such as BlackRock, CME Group, and Cboe Global Markets. According to TipRanks, Cyprys has an average return of 4.4% and a 54.07% success rate on recommended stocks. Currently, the analyst consensus on T Rowe Price is a Moderate Sell with an average price target of $99.00. TROW market cap is currently $23.56B and has a P/E ratio of 12.13. Based on the recent corporate insider activity of 108 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TROW in relation to earlier this year. Last month, Dorothy C Sawyer, an Insider at TROW sold 2,000.00 shares for a total of $190,860.00.
CNBC
14-05-2025
- Business
- CNBC
This private equity stock is set to jump after U.S. and China reach trade deal, Morgan Stanley says
Morgan Stanley moved off the sidelines on KKR after the China-U.S. trade deal sweetened the macro outlook. Analyst Michael Cyprys upgraded shares of the investment management firm to overweight from equal weight and hiked his price target by $30 to $150. Cyprys' new target implies upside of 18.2% over Tuesday's close. Cyprys' call comes after the U.S. and China agreed to temporarily slash reciprocal levies on one another following weekend negotiations. The announcement eased investor fears of a trade war between the two countries and sparked a major market rally in U.S. stocks on Monday. "[We're] leaning into risk ... on the back of greater than expected tariff de-escalation with China and scope for better than feared macro path ahead with lower recession probability, less upward inflation pressure and reduced tail risk," Cyprys wrote in a Wednesday note to clients. "Combined, these macro conditions can improve market confidence in a potential capital markets recovery and re-accelerate the private markets flywheel, supporting a robust earnings outlook for KKR." Cyprys said KKR should be able to benefit from secular tailwinds within private markets such as private credit, private wealth and insurance. The firm also raised its earnings per share outlooks for 2025 and 2026. More broadly, the analyst said the stock is a way to play a recovery in capital markets. Cyprys said KKR is in a particular good stock to capture upside given it is a high-quality growth franchise. Despite shares rising about 0.5% before the bell Wednesday, the stock has dropped more than 14% in 2025. That decline puts shares at an "attractive" spot for investors, he said. Cyprys' upgrade puts him in line with the majority of analysts on Wall Street with buy-equivalent ratings, per LSEG.
